BioPharma Asia Convention 2017 – the J&J Innovation JLabs’ Singapore Quickfire Challenge Launch Ceremony

biopharma-jlabs

BioPharma Asia Convention 2017 - the J&J Innovation JLabs’ Singapore Quickfire Challenge Launch Ceremony

aca-cam01-3455
Holmusk Business Development Director, Latt Mansor, joins the J&J Innovation JLabs’ Singapore Quickfire Challenge – Metabolic Disease Innovation panel session at BioPharma Asia Convention 2017 on 22 March 2017.

BioPharma Asia Convention 2017 – Singapore QuickFire Challenge Launch Ceremony

Panel Discussion: Collaboration by industry, government and academia in developing innovative solutions for diabetes and other metabolic diseases

“Startups play a role in challenging conventional healthcare systems with new ideas, new ways of thinking,” said Latt Mansor. He addressed the importance of continuous innovation in order to deliver solutions that could halt epidemics like diabetes. For instance, the cutting-edge digital intervention services tailored to people with diabetes such as GlycoLeap could help encourage people to combat diabetes.

One of the panelists, John Beck, CEO of Professorial Associates (Asia) Pte Ltd, living with diabetes, shared his real life stories and needs to the industry experts from the patient’s perspective.

Sue-Anne Toh, Senior Consultant, Division of Endocrinology of National University Health System, and Monica Mohan, Head of Partnership Propositions and Business Development of Allianz, discussed the diabetes ecosystem in Asia and the opportunities around diabetes management for insurers.

The panel discussion concluded with the Singapore Quickfire Challenge – Metabolic Disease Innovation by JLabs launch ceremony.

About Singapore QuickFire Challenge – Metabolic Disease Innovation

Johnson & Johnson Innovation, JLABS (JLABS) in collaboration with Exploit Technologies Pte Ltd (ETPL) and Singapore-MIT Alliance for Research and Technology (SMART), have launched the Singapore QuickFire Challenge – Metabolic Disease Innovation to attract game-changing, early stage innovations that address this critical health concern. For more information, visit here.

Latt

Speaker: Latt Mansor
Director, Business Development at Holmusk

22  March 2017
from 17:00 to 18:00 (SGT)
BioPharma Asia Convention 2017, Singapore

Suntec Singapore International Exhibition & Convention Centre
1 Raffles Boulevard, Suntec City,
Singapore 039593